Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

NCT00023166 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Neoplasm
Lymphomas
Neoplasm Metastasis

Interventions

DRUG: PEG-paclitaxel

Sponsor

Enzon Pharmaceuticals, Inc.